Volume 18, Issue 10, Pages (October 2016)

Slides:



Advertisements
Similar presentations
Volume 36, Issue 6, Pages (June 2015)
Advertisements

Continuous Delivery of Neutralizing Antibodies Elevate CCL2 Levels in Mice Bearing MCF10CA1d Breast Tumor Xenografts  Min Yao, Curtis Smart, Qingting.
Cell Physiol Biochem 2013;32: DOI: /
CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation  G.-W. Kim, M.-S. Han, H.-R. Park, E.-J.
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Volume 17, Issue 5, Pages (May 2015)
Expression Profiling of Galectin-3-Depleted Melanoma Cells Reveals its Major Role in Melanoma Cell Plasticity and Vasculogenic Mimicry  Alexandra A. Mourad-Zeidan,
Volume 15, Issue 6, Pages (June 2009)
Cell Surface CD74–MIF Interactions Drive Melanoma Survival in Response to Interferon-γ  Keiji Tanese, Yuuri Hashimoto, Zuzana Berkova, Yuling Wang, Felipe.
The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis  Rana Herro, Ricardo Da S. Antunes, Amelia R. Aguilera,
Volume 17, Issue 7, Pages (July 2015)
DNMT3B Overexpression by Deregulation of FOXO3a-Mediated Transcription Repression and MDM2 Overexpression in Lung Cancer  Yi-Chieh Yang, MS, Yen-An Tang,
Deregulation of SLIT2-Mediated Cdc42 Activity Is Associated with Esophageal Cancer Metastasis and Poor Prognosis  Ruo-Chia Tseng, PhD, Jia-Ming Chang,
Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells
Volume 19, Issue 9, Pages (September 2017)
Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI- 258) and its Therapeutic Implications  Shalini S. Yadav, Jinyi.
Volume 19, Issue 7, Pages (July 2017)
Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT  Zhen-Yu He, San-Gang Wu, Fang Peng,
Volume 137, Issue 2, Pages e2 (August 2009)
MicroRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7  Yixiong Lin, Jianjun Liu, Yuqi Huang,
CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation  G.-W. Kim, M.-S. Han, H.-R. Park, E.-J.
Myung Jin Son, Kevin Woolard, Do-Hyun Nam, Jeongwu Lee, Howard A. Fine 
Restoration of Corneal Transparency by Mesenchymal Stem Cells
Intermittent cyclic mechanical tension promotes endplate cartilage degeneration via canonical Wnt signaling pathway and E-cadherin/β-catenin complex cross-talk 
Hydrogen Sulfide Demonstrates Promising Antitumor Efficacy in Gastric Carcinoma by Targeting MGAT5  Rui Wang, Qilin Fan, Junjie Zhang, Xunan Zhang, Yuqi.
Interleukin-17 and Prostaglandin E2 Are Involved in Formation of an M2 Macrophage- Dominant Microenvironment in Lung Cancer  Lunxu Liu, MD, PhD, Dongxia.
Volume 13, Issue 6, Pages (November 2015)
Volume 16, Issue 9, Pages (August 2016)
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Volume 11, Issue 2, Pages (February 2005)
Volume 19, Issue 3, Pages (March 2017)
Pulmonary Fibroblasts Induce Epithelial Mesenchymal Transition and Some Characteristics of Stem Cells in Non-Small Cell Lung Cancer  Yasushi Shintani,
Volume 19, Issue 12, Pages (December 2017)
Activated Leukocyte Cell-Adhesion Molecule (ALCAM) Promotes Malignant Phenotypes of Malignant Mesothelioma  Futoshi Ishiguro, MD, Hideki Murakami, MD,
Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung.
Volume 132, Issue 7, Pages (June 2007)
Volume 20, Issue 3, Pages e4 (March 2017)
Volume 23, Issue 5, Pages (May 2018)
Volume 22, Issue 10, Pages (October 2014)
Volume 141, Issue 6, Pages e5 (December 2011)
Molecular Therapy - Nucleic Acids
Volume 143, Issue 1, Pages e7 (July 2012)
SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer
Volume 19, Issue 9, Pages (September 2017)
Volume 7, Issue 2, Pages (February 2010)
Volume 142, Issue 7, Pages e2 (June 2012)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Molecular Therapy - Nucleic Acids
Volume 15, Issue 4, Pages (April 2016)
IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling  Yasushi.
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Volume 19, Issue 13, Pages (June 2017)
Anke Sparmann, Dafna Bar-Sagi  Cancer Cell 
Lu Zheng, Nan You, Xiaobing Huang, Huiying Gu, Ke Wu, Na Mi, Jing Li 
SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer
Volume 13, Issue 11, Pages (December 2015)
Volume 19, Issue 1, Pages (April 2017)
Figure 1. RSPO3 expression is upregulated in bladder cancer
Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer  Yalei Cui, Xiaoyuan Yang, Xiaobo Zhang  Molecular.
TSLP Is a Potential Initiator of Collagen Synthesis and an Activator of CXCR4/SDF-1 Axis in Keloid Pathogenesis  Jung U Shin, Seo Hyeong Kim, Hyeran Kim,
Volume 34, Issue 5, Pages (May 2011)
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Volume 19, Issue 1, Pages (April 2017)
MiR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1  Qi Song, Quanbo Ji, Jingbo Xiao, Fang Li, Lingxiong Wang, Yin.
Molecular Therapy - Nucleic Acids
Volume 31, Issue 6, Pages (December 2009)
Volume 15, Issue 11, Pages (June 2016)
Molecular Therapy - Nucleic Acids
Volume 8, Issue 6, Pages (June 2017)
Volume 12, Issue 5, Pages (November 2005)
Presentation transcript:

Volume 18, Issue 10, Pages 636-646 (October 2016) CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer  Makito Miyake, Shunta Hori, Yosuke Morizawa, Yoshihiro Tatsumi, Yasushi Nakai, Satoshi Anai, Kazumasa Torimoto, Katsuya Aoki, Nobumichi Tanaka, Keiji Shimada, Noboru Konishi, Michihiro Toritsuka, Toshifumi Kishimoto, Charles J. Rosser, Kiyohide Fujimoto  Neoplasia  Volume 18, Issue 10, Pages 636-646 (October 2016) DOI: 10.1016/j.neo.2016.08.002 Copyright © 2016 The Authors Terms and Conditions

Figure 1 CXCL1 expression and recruitment of stromal cells in human non-muscle invasive bladder cancer. (A) Representative expression status of CXCL1, CD204, αSMA, MMP2, and E-cadherin in human bladder cancer tissues. All images were captured at 200× magnification except for αSMA, for which the images were captured at 100× and 400× magnification. (B) Progression-free survival curves of patients with NMIBC after TURBT according to the expression level of CXCL1. (C–F) comparison of CXCL1 expression levels with (C) the number of tumor-infiltrating TAMs, (D) induction level of CAFs (CAF score), (E) percentage of MMP2-positive cells, and (F) percentage of membranous E-cadherin-positive cells. In the box-and-whisker plot or bar charts, significance (* P < 0.05, ** P < 0.05) was assessed by the Mann–Whitney U test. Neoplasia 2016 18, 636-646DOI: (10.1016/j.neo.2016.08.002) Copyright © 2016 The Authors Terms and Conditions

Figure 2 Induction of TAMs and CAFs by IL-6 in human bladder cancer tissues and confirmation by in vitro experiments. (A) Representative expression status for IL-6 in human bladder cancer tissues. Images were captured at 200× magnification. (B) The interrelationship between the percentage of IL-6-positive cancer cells and the number of tumor-infiltrating TAMs was examined using Spearman’s correlation. Spearman r was found to be 0.68 (95% confidence interval, 058–0.76). (C) Comparison of the percentage of IL-6-positive cancer with the induction level of CAFs (CAF score). (D) Morphological changes of THP-1 cells by PMA and IL-4 treatment. THP-1 cells were treated with 200 nM PMA for 24 h to differentiate them into resting macrophages (middle), followed by treatment with IL-4 (20 ng/mL) for 48 h (right). (E) Western blot analysis for confirming the generation of TAMs and CAFs. THP-1 cells were treated with a combination of PMA and 20 ng/mL of CXCL1, IL-6, or TGF-β, separately. Upregulation of CD204 indicates differentiation into TAMs. NIH3T3 cells were treated with 20 ng/mL of CXCL1, IL-6, or TGF-β, separately. Upregulation of αSMA indicates the activation of fibroblasts, which are known to be CAFs. Neoplasia 2016 18, 636-646DOI: (10.1016/j.neo.2016.08.002) Copyright © 2016 The Authors Terms and Conditions

Figure 3 Association of CXCL1 production in TAMs/CAFs with invasion potential of human bladder cancer. (A) Dual immunofluorescence staining analysis for CD204 or αSMA (green) and CXCL1 (red) shows the expression of CXCL1 in TAMs and CAFs in the tumoral area. Overlay images and their magnified images are shown (2 panels on the right). Original magnification, 200×. (B) CXCL1 mRNA expression level was determined by real-time RT-PCR. Expression levels are the result of 3 experiments and are expressed as the mean ± SD relative to that of UROtsa, which is defined as 1. (C) THP-1 and NIH3T3 cells were infected with lentiviral constructs harboring empty vectors (LvNega) or CXCL1 expression vectors (LvCXCL1). Western blot analysis demonstrated altered CXCL1 expression in both cell lines. The changes in the expression levels of CD204 and αSMA were evaluated in infected THP-1 and NIH3T3 cells, respectively. Actin served as the loading control. (D) MGH-U3 and T24 cells were suspended in the conditioned media collected from manipulated TAMs and CAFs and subjected to in vitro invasion assays. Data are expressed as the mean ± SD of 3 independent experiments conducted in triplicate; *, P < 0.05, **, and P < 0.01. Neoplasia 2016 18, 636-646DOI: (10.1016/j.neo.2016.08.002) Copyright © 2016 The Authors Terms and Conditions

Figure 4 Association of CXCL1 production in TAMs/CAFs with strong adhesion to bladder cancer cells and formation of homogenous multicellular spheroids. Bladder cancer cells T24 and MGH-U3 were labeled with PKH67 (green dye). THP-1-derived TAMs and NIH3T3-drived CAFs were labeled with PKH26 (red dye). After labeling, cancer cells and stromal cells were mixed at the same number (5×103 cells/well) and plated into a 3D culture plate. Photographs of randomly selected spheroids were captured 3 days after plating. Representative spheroids are shown as follows: (A) spheroids of the co-culture of T24 cells and TAMs; (B), spheroids of T24 cells and TAMs treated with anti-CXCL1-neutralizing antibody; C, spheroids of the co-culture of MGH-U3 cells and CAFs; (D) spheroids of MGH-U3 cells and CAFs treated with anti-CXCL1-neutralizing antibody. Original magnification, 400×. Neoplasia 2016 18, 636-646DOI: (10.1016/j.neo.2016.08.002) Copyright © 2016 The Authors Terms and Conditions

Figure 5 Subcutaneous xenograft models and orthotopic bladder cancer models using human bladder cancer cells, TAMs, and CAFs. (A) MGH-U3 cells (1×106) mixed with LvCXCL1-TAMs or LvCXCL1-TAMs (0.5×106) and MGH-U3 cells (1×106) not mixed with TAM were injected subcutaneously into athymic nude mice. Similar experiments were conducted using UMUC3 cells and TAMs (B), MGH-U3 cells and CAFs (C), and UMUC3 cells and CAFs (D). Tumor size, recorded over 21 days, was plotted as mean ± SD for the 3 groups (n = 8/group). Tumor sizes on the 21st day were compared by the Mann–Whitney U test (* P < 0.05, ** P < 0.05; ns = no significance). (E) The resected tumors were analyzed by immunohistochemical staining for CD204, αSMA, E-cadherin, and MMP2. Representative pictures for tumors of MGH-U3/TAMs and MGHU-3/CAFs are shown. (F and G) The orthotopic models using SCID mice were generated by injecting the mixture of MGH-U3 cells (2×106) and the manipulated TAMs or CAFs (1×106). Two weeks after injection, the bladders of mice were resected to evaluate intravesical tumor implantation rate by H&E staining for each group (n = 8/group). (H) Intravesical recurrence-free survival curves in patients with NMIBC after TURBT according to the number of tumor-infiltrating TAMs (left) and the CAF score (right). Neoplasia 2016 18, 636-646DOI: (10.1016/j.neo.2016.08.002) Copyright © 2016 The Authors Terms and Conditions

Figure 6 Schematic diagram of the proposed mechanism for crucial roles of CXCL1 in human urothelial carcinoma of the bladder. TAM, tumor-associated macrophage; CAF, cancer-associated fibroblast; CXCL1, chemokine (C-X-C motif) ligand 1; MMP, matrix metalloprotease. Neoplasia 2016 18, 636-646DOI: (10.1016/j.neo.2016.08.002) Copyright © 2016 The Authors Terms and Conditions

Supplementary Figure S1 mRNA expression level of CXCR2 was determined by real-time RT-PCR. Expression levels are the result of 3 experiments and are expressed as the mean ± SD, relative to that of UROtsa, which is defined as 1. Neoplasia 2016 18, 636-646DOI: (10.1016/j.neo.2016.08.002) Copyright © 2016 The Authors Terms and Conditions